Authors

Talita Barretp, Baptist Health South Florida,
Laura Benitez, Miami Cancer InstituteFollow
Uzma Farooq, Baptist Health South FloridaFollow
Naiara Fraga Braghiroli, Miami Cancer InstituteFollow
Samantha Sugerik, Baptist Health South Florida

Use of Imiquimod 5% Cream for the Treatment of Lentigomaligna on the Face

Publication Date

11-20-2013

Content Type

Article

Publisher's Site:

View at Publisher Website

Comments

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium , provided the original work is properly cited, the use is non-commercial and no modificat ions or adaptations are made. © 2023 The Authors. JEADV Clini cal Practice published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.

Citation

Macedo, T. B., Benitez, L., Farooq, U., Sugerik, S., & Braghiroli, N. F. (2023, 2023/11/20). Use of Imiquimod 5% cream for the treatment of lentigo maligna on the face. JEADV Clinical Practice, n/a(n/a). https://doi.org/https://doi.org/10.1002/jvc2.314